ExL Pharma will host the Cloud Computing for Life Sciences R&D Summit December 4-5 at the Rittenhouse Hotel in Philadelphia.
Cloud computing offers exponentially increased processing power and data storage that makes past computer capabilities seem miniscule. Scientists are just scratching the surface of what can be done with next generation genomic sequencing, large-scale chemistry solutions, pharmacodynamics and perhaps new areas of research that haven’t been discovered yet.
The two-day program focuses on examples of how pharmaceutical companies have implemented the new technology. Speakers will share organizational challenges and scientific triumphs. Large pharma companies, universities, and independent research institutions are all represented on the speaker staff, demonstrating the new versatility that is unlocked by this new technology.
The diverse speaker staff draws from some of the leading life science research institutions and companies, including the Broad Institute, Brystol-Myers Squibb, Johnson & Johnson, Purdue Pharma, Merck, Boehringer Ingelheim, Celgene, GlaxoSmithKline, and the University of Pennsylvania. All of these institutions have successfully enhanced the scope and quality of their research using cloud servers to expand processing power and storage capabilities.
To find out more information regarding attending the Cloud Computing for Life Sciences R&D Summit, please visit http://www.exlpharma.com/events/cloud-computing-life-sciences-rd or contact Dave Hoffman at [email protected]
About ExL Pharma
ExL Pharma, a division of ExL Events, Inc., is the industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe, Latin America and various markets. Behind our diverse pharmaceutical event portfolio, ExL’s experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.